SEHK:1509

Stock Analysis Report

Harmonicare Medical Holdings

Executive Summary

Harmonicare Medical Holdings Limited, an investment holding company, operates obstetrics and gynecology hospitals that provide inpatient and outpatient healthcare services.

Snowflake

Fundamentals

Reasonable growth potential with mediocre balance sheet.

Share Price & News

How has Harmonicare Medical Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

n/a

1509

4.2%

HK Healthcare

3.1%

HK Market


1 Year Return

-9.3%

1509

-25.0%

HK Healthcare

0.5%

HK Market


Shareholder returns

1509IndustryMarket
7 Dayn/a4.2%3.1%
30 Dayn/a-1.3%-1.8%
90 Dayn/a-3.2%-4.8%
1 Year-9.3%-9.3%-23.4%-25.0%4.1%0.5%
3 Year-52.3%-53.0%-32.4%-36.4%15.8%4.2%
5 Yearn/a-29.9%-36.0%18.9%-0.9%

Price Volatility Vs. Market

How volatile is Harmonicare Medical Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Harmonicare Medical Holdings undervalued compared to its fair value and its price relative to the market?

1.2x

Price to Book (PB) ratio


Share Price vs. Fair Value

Undervalued: Insufficient data to calculate 1509's fair value to establish if it is undervalued.

Significantly Undervalued: Insufficient data to calculate 1509's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: 1509 is unprofitable, so we can't compare its PE Ratio to the Healthcare industry average.

PE vs Market: 1509 is unprofitable, so we can't compare its PE Ratio to the Hong Kong market.


Price to Earnings Growth Ratio

Low PEG Ratio: Insufficient data to calculate 1509's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 1509 is good value based on its PB Ratio (1.2x) compared to the HK Healthcare industry average (1.4x).


Next Steps

Future Growth

How is Harmonicare Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

44.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1509 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 1509 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 1509 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 1509's revenue (12.3% per year) is forecast to grow faster than the Hong Kong market (10% per year).

High Growth Revenue: 1509's revenue (12.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Information is not available.


Next Steps

Past Performance

How has Harmonicare Medical Holdings performed over the past 5 years?

-49.6%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: 1509 is unprofitable, and losses have increased over the past 5 years at a rate of -49.6% per year.

Accelerating Growth: Unable to compare 1509's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 1509 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (5.6%).


Return on Equity

High ROE: 1509 has a negative Return on Equity (-17.52%), as it is currently unprofitable.


Return on Assets

ROA vs Industry: 1509 is currently unprofitable, so its Return on Assets is negative.


Return on Capital Employed

ROCE Improving: 1509 is currently unprofitable, so its Return on Capital Employed is negative.


Next Steps

Financial Health

How is Harmonicare Medical Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 1509's short term assets (CN¥346.9M) exceeds its short term liabilities (CN¥296.0M)

Long Term Liabilities: 1509's short term assets (346.9M) exceeds its long term liabilities (154.8M)


Debt to Equity History and Analysis

Debt Level: 1509's debt to equity ratio (6.5%) is considered satisfactory

Reducing Debt: 1509's debt to equity ratio has increased from 0% to 6.5% over the past 5 years.

Debt Coverage: 1509's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 1509's interest payments on its debt are well covered by EBIT.


Balance Sheet

Information is not available.

Information is not available.


Next Steps

Dividend

What is Harmonicare Medical Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

company0%marketbottom25%2.3%markettop25%6.3%industryaverage2.6%forecastin3Years0%

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate 1509's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 1509's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if 1509's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 1509's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: 1509 is not paying a notable dividend for the Hong Kong market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 1509's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

What is the CEO of Harmonicare Medical Holdings's salary, the management and board of directors tenure and is there insider trading?

2.0yrs

Average management tenure


CEO

Yuming Lin (49yo)

5yrs

Tenure

CN¥519,000

Compensation

Mr. Yuming Lin is the Founder of Bosheng Medical Investment Co., Inc. and has been its Chairman and President since December 2007. Mr. Lin is the Founder, Chairman, CEO and President of Harmonicare Medical ...


CEO Compensation Analysis

Information is not available.

Compensation vs Earnings: Yuming's compensation has increased whilst the company is unprofitable.


Management Age and Tenure

2.0yrs

Average Tenure

47yo

Average Age

Experienced Management: 1509's management team is considered experienced (2 years average tenure).


Board Age and Tenure

4.4yrs

Average Tenure

48.5yo

Average Age

Experienced Board: 1509's board of directors are considered experienced (4.4 years average tenure).


Insider Trading

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown


Management Team

  • Aries Cheung (54yo)

    Joint Company Secretary

    • Tenure: 1.3yrs
  • Yuming Lin (49yo)

    Chairman

    • Tenure: 5yrs
    • Compensation: CN¥519.00k
  • Zhifeng Fang (45yo)

    VP & Executive Director

    • Tenure: 4.4yrs
  • Wei Chen (40yo)

    VP & Joint Company Secretary

    • Tenure: 0yrs
  • Wenfeng Li (64yo)

    Vice-President of Sourcing and Audit Management

    • Tenure: 2yrs
  • Jinhui Ren (43yo)

    VP & CFO

    • Tenure: 0yrs

Board Members

  • Jun Xu (51yo)

    Non-Executive Director

    • Tenure: 2.7yrs
  • Yuming Lin (49yo)

    Chairman

    • Tenure: 5yrs
    • Compensation: CN¥519.00k
  • Zhifeng Fang (45yo)

    VP & Executive Director

    • Tenure: 4.4yrs
  • Yuguo Lin (46yo)

    Non-Executive Director

    • Tenure: 4.4yrs
  • Aiguo Kong (52yo)

    Independent Non-Executive Director

    • Tenure: 4.4yrs
    • Compensation: CN¥200.00k
  • Lan Fang (48yo)

    Independent Non-Executive Director

    • Tenure: 4.4yrs
    • Compensation: CN¥200.00k
  • Jiang Nan Cai (62yo)

    Independent Non-Executive Director

    • Tenure: 4.4yrs
    • Compensation: CN¥200.00k
  • Jianwei Qiu (43yo)

    Non-Executive Director

    • Tenure: 2.7yrs

Company Information

Harmonicare Medical Holdings Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Harmonicare Medical Holdings Limited
  • Ticker: 1509
  • Exchange: SEHK
  • Founded: 2002
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: HK$1.517b
  • Shares outstanding: 743.48m
  • Website: https://www.hemeiyl.com

Number of Employees


Location

  • Harmonicare Medical Holdings Limited
  • No. A2 Xiaoguan Beili
  • Beiyuan Road
  • Beijing
  • 100029
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
1509SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDJul 2015
157DB (Deutsche Boerse AG)YesOrdinary SharesDEEURJul 2015

Biography

Harmonicare Medical Holdings Limited, an investment holding company, operates obstetrics and gynecology hospitals that provide inpatient and outpatient healthcare services. The company operates through Spe ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/08/01 13:00
End of Day Share Price2019/07/30 00:00
Earnings2018/12/31
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.